The 14th edition EMD Serono’s Specialty Digest continues its. Getting the picture of what’s happening now is the value of. Managed Markets, EMD Serono, Inc. Dear managed care colleagues: As we launch the 9th edition of the EMD Serono Specialty Digest, we hope that this year’s.

Author: Mezikus Akinole
Country: Djibouti
Language: English (Spanish)
Genre: Video
Published (Last): 5 December 2013
Pages: 88
PDF File Size: 16.51 Mb
ePub File Size: 10.38 Mb
ISBN: 950-7-38497-574-3
Downloads: 65704
Price: Free* [*Free Regsitration Required]
Uploader: Zulkit

Cure Rates Are Rising. Total Health Care Spending Growth.

EMD Serono Specialty Digest, 9th Edition

Reductions in Hep C Complications. Welcome to our new site. Rebates Reduced Price Growth. The Digest is an annual industry resource that provides market specialyy on pharmacy benefit manager PBM and health insurance plans’ management of biopharmaceuticals and identifies common trends occurring across plans.

Pragmatic Solutions to Address Cost. The 14 th edition EMD Serono Specialty Digest outlines the results of a survey of 59 commercial health plans representing nearly million covered lives in Patients Facing Serrono Cost Sharing.

Slowdown in Medicine Spending. The Complexity of Clinical Trials.

EMD Serono Specialty Digestâ„¢ 14th Edition

Better Use of Medicines. Medicines Offer Cost Containment. The sample included commercial health plan personnel who are responsible for specialty drug-related services and responded to emailed invitations from Artemetrx Specialty Drug Solutions. We are working hard to be a leader in identifying current and future trends in the management of specialty pharmaceuticals.


State Targeting in Economic Plans. The specialty pharmacy landscape is always changing. Growth in Medicine Prices. Venture Capital Fueling Innovation. Market for Is Medicines Changing. Your Contact Melissa Beglin, View original content with multimedia: Among the interesting trends identified this year: Seventy-six percent of plans cover injectable drugs under the pharmacy benefit only.

Brand Sales Face Competition. Spending on Cancer Medicines.

PhRMA | Chart Packs

Commercial Success of Approved Meds. The founding family remains the majority owner of the publicly listed corporate group. Greater Access to Cancer Medicines. Stepping Stones for Innovation. New areas digeest focus for Download Download the document to your computer to access it offline.

Furthermore, most plans 78 percent require injectable drugs for MS to be dispensed through a contracted specialty pharmacy provider SPP. Increases in US Life Expectancy. For more than 40 years, the business has integrated cutting-edge science, innovative products and industry-leading patient support and access programs. Sincethere was a percent increase in health plans that are using site-of-care programs – hospitals, community offices, ambulatory infusion suites, or home-based settings.

High Cost Sharing Digesst Adherence. The survey, which was fielded from November 15, to December 28,measured the use of common drug benefit management specialtyy, emerging challenges and opportunities, and assessments of the success of various initiatives.

EMD Serono Specialty Digest shows more interest in site of care by payers – Pharmaceutical Commerce

Table of contents Easily move digext the document, finding the part you want in the convenient table of contents. Medicine Spending in Next Decade.

  KAVO 4444 PDF

Drug Discovery and Development. Most Common Prescribing Problem. Search keyword Search for words or phrases and see all the search results right away. Among the interesting trends identified this year:.

Decline in New Medicine Returns. Of those that do not have a site-of-care program, more than half plan to implement one in the next 12 months. Around 50, employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.

View original content with multimedia: Today, the business has 1, employees around the country with commercial, clinical and research operations based in the company’s home specialyy of Massachusetts.

Challenging the US in Innovation. Innovation in Rare Diseases. New Generics Are Adopted Regularly.